Trinity Biotech Plc's (TRIB) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Trinity Biotech Plc  (NASDAQ: TRIB)
 



  Trinity Biotech Plc Outlook

On May 23 2024 the Trinity Biotech Plc provided following guidance

Trinity Biotech Plc. has announced its financial results for Q1 2024 and has reiterated its guidance for the future. The company stated that they are on track to achieve approximately $20 million of annualized run-rate EBITDASO by Q2 2025, with annualized revenues expected to reach around $75 million by that time.

This projection indicates that Trinity Biotech is confident in its business performance and growth trajectory. By continuing to focus on their strategic goals and objectives, the company aims to reach significant financial milestones within the next year.

Overall, Trinity Biotech's outlook for the future is positive, as they continue to make progress towards their financial targets and position themselves for sustainable growth in the coming years.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.